Hey, sleep researchers, here’s an idea: If you want us to get more sleep, quit finding news that keeps us up at night. 
From Insomnia News
Older adults with sleeping problems benefit from cognitive behavioural therapy A form of counselling called cognitive behavioural therapy is more effective than sleeping pills at relieving insomnia in older …
From Insomnia News
Sepracor , which focuses on respiratory and central-nervous-system disorders, has been one of 2006’s most volatile pharmaceutical stocks.
From Insomnia News
Booming sales of the blockbuster insomnia drug Lunesta helped boost revenue for Sepracor Inc.
From Insomnia News
Sports fans may find themselves wanting to invest in the sports-memorabilia industry, a lucrative play for some collectors.
From Insomnia News
Women are twice as likely to suffer from insomnia than men, and insomnia tends to increase with age.
From Insomnia News
Hoping to help Americans snooze while also putting to rest controversies dogging the crowded group of prescription sleeping pills, a drugmaker has kicked off a nearly $100 million consumer ad campaign for its …
From Insomnia News
Insomnia is a disorder that can cause many problems, both physical and mental. It can interfere and disrupt a normal life, it contributes to headaches, dizziness, mental exhaustion, confusion, memory problems, …
From Insomnia News
Takeda Pharmaceuticals North America Inc. is launching a nearly $100 million ad campaign for a sleeping pill that is not a controlled substance.
From Insomnia News
Sanofi-aventis today announced results from a study that demonstrated AMBIEN CR is well-tolerated and effective in improving sleep onset and maintenance for up to six months in patients with chronic primary …
From Insomnia News
Sleep Disorder Information
